Patents Assigned to Uni-Pharma Kleon Tstetis Pharmaceuticals Laboratories S.A.
  • Dry powder comprising levothyroxine sodium administrated via inhalator
    Patent number: 8333192
    Abstract: A device comprising an inhaler suitable for administration of a stable dry powder blend is described, which contains a blend comprising a thyroid hormone, in particular levothyroxine sodium, and other additives such as lactose particles, sodium starch glycolate, magnesium stearate, and talc silicified.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: December 18, 2012
    Assignee: Uni-Pharma Kleon Tstetis Pharmaceuticals Laboratories S.A.
    Inventor: Ioulia Tseti